Veracyte, Inc. Q1 2025 10-Q Filed
Ticker: VCYT · Form: 10-Q · Filed: May 8, 2025 · CIK: 1384101
| Field | Detail |
|---|---|
| Company | Veracyte, Inc. (VCYT) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, healthcare, medical-diagnostics
Related Tickers: VCYT
TL;DR
VERACYTE (VCYT) Q1 2025 10-Q is in, check financials for latest performance update.
AI Summary
Veracyte, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025, comparing it to the same period in 2024. Key financial data and segment performance are presented, with the company operating in the medical laboratories sector.
Why It Matters
This filing provides investors and analysts with the latest financial results and operational details for Veracyte, Inc., crucial for understanding the company's performance and future outlook in the medical diagnostics sector.
Risk Assessment
Risk Level: medium — As a publicly traded company in the healthcare sector, Veracyte faces inherent market, regulatory, and competitive risks detailed in its SEC filings.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-01-01 — Reporting Period Start Date (Indicates the start of the financial quarter being reported.)
- 2024-12-31 — Prior Year End Date (Used for comparative balance sheet information.)
Key Players & Entities
- VERACYTE, INC. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date of the 10-Q
- SOUTH SAN FRANCISCO, CA (location) — Company's business and mailing address
- CALDEROME INC (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 8, 2025.
What is Veracyte, Inc.'s primary business classification?
Veracyte, Inc. is classified under SERVICES-MEDICAL LABORATORIES [8071].
What was Veracyte, Inc.'s former company name?
Veracyte, Inc.'s former company name was CALDEROME INC.
What is the company's primary business address?
The company's business address is 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA 94080.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding VERACYTE, INC. (VCYT).